Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Dec 21, 2020; 26(47): 7550-7567
Published online Dec 21, 2020. doi: 10.3748/wjg.v26.i47.7550
Table 2 Tumor and pathological features of patients with multiple gastrointestinal stromal tumors, n (%)

PKUPH patients, n = 121
Literature-based patients, n = 1611
Total patients, n = 1731
Siten = 40n = 330n = 370
Stomach22 (55.00)121 (36.67)143 (38.65)
Small intestine17 (42.50)201 (60.91)218 (58.92)
Duodenum1 (2.50)27 (8.18)28 (7.57)
Jejunum4 (10.00)68 (20.61)72 (19.46)
Ileum3 (7.50)25 (7.58)28 (7.57)
Other sites1 (2.50)8 (2.42)9 (2.43)
Involving organn = 12n = 156n = 168
Single9 (75.00)108 (69.23)117 (69.64)
Two or more3 (25.00)48 (30.77)51 (30.36)
Size in cmn = 40n = 315n = 355
Range0.10-8.000.05-27.000.05-27.00
≤ 122 (55.00)94 (29.84)116 (32.68)
1-24 (10.00)65 (20.64)69 (19.44)
2-511 (27.75)98 (31.11)109 (30.70)
5-103 (7.50)45 (14.29)48 (13.52)
> 100 (0.00)13 (4.13)13 (3.56)
Mean (SD)2.00 (2.16)3.26 (3.50)3.12 (3.40)
Cellular typen = 40n = 180n = 220
Spindle40 (100.00)137 (76.11)177 (80.46)
Epithelial0 (0.00)23 (12.78)23 (10.46)
Mixed0 (0.00)20 (11.11)20 (9.09)
Mitosis, /50 HPFsn = 35n = 202n = 237
Range0-90-480-48
≤ 533 (94.29)174 (86.14)207 (87.34)
5-102 (5.71)15 (7.43)17 (7.17)
> 100 (0.00)13 (6.44)13 (5.49)
Mean (SD)3.86 (1.87)3.32 (5.91)3.40 (5.50)
Risk classificationn = 35n = 249n = 284
Very low risk20 (57.14)54 (21.69)74 (26.05)
Low risk10 (28.57)113 (45.38)123 (43.31)
Median risk3 (8.57)26 (10.44)29 (10.21)
High risk2 (5.71)56 (22.49)58 (20.42)
CD117n = 35n = 149n = 184
Positive35 (100.00)144 (96.64)179 (97.28)
CD34n = 35n = 140n = 175
Positive12 (34.29)114 (81.43)126 (72.00)
Ki-67n = 35n = 47n = 82
Range0-201-33.80-33.8
Mean (SD)3.83 (4.85)3.96 (5.11)3.91 (4.97)
Desminn = 35n = 98n = 133
Positive1 (2.86)1 (1.02)2 (1.50)
S-100n = 35n = 108n = 143
Positive1 (2.86)32 (29.63)33 (23.08)
SMAn = 35n = 120n = 155
Positive5 (14.29)19 (15.83)24 (15.48)